Vytorin/Inegy ezetimibe/simvastatin: Phase III ongoing

The partners said an independent panel of clinical and biostatistics experts recommended "focusing the primary endpoint" of the double-blind Phase III ENHANCE trial "to the common carotid artery, to e...